Clinical Trial Update: Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing ursodeoxycholic acid to placebo for reducing severity of gestational diabetes diagnosed at 24-28 weeks, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Gestational Diabetes | Phase 3 | Status: COMPLETED